Skip to content

Aged European Population Quality of Life in Infectious Diseases

Aged European Population Quality of Life in Infectious Diseases - AEQUI

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00029952
Enrollment
305
Registered
2022-09-12
Start date
2022-11-24
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frailty A49.9 A41 J22

Interventions

Group 1: Patients are enrolled in the case group who are 65 years of age or older and have either a febrile or severe upper respiratory tract infection, or in whom bacteria have been detected in the b

Sponsors

Uniklinik Köln - Zentrum für Innere Medizin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: Case: The study will include patients aged above 65 years of age presenting to emergency department, infectious disease, internal medicine or geriatric hospital wards with bacteraemia and/or acute respiratory infection Informed consent form signed Control: The typical control patient will be of the same age (+/- 3 years, but aged above 65 years), same sex, without suspicion of infection and hospitalized during the past or upcoming month in the same centre. Informed consent form signed

Exclusion criteria

Exclusion criteria: • Bed-ridden or terminally ill patient (based upon a threshold of ADL: =2 TBD, or Clinical Frailty scale: =8) • Patients that refuse the 3- and 6-months follow-up phone call assessments • Patients that will not be able to answer the 3- and 6-months follow-up phone call assessments via a nurse • Patients with persistent hemiplegia (Stroke), blindness, full dementia.

Design outcomes

Primary

MeasureTime frame
Quantify the impact of acute respiratory infection (ARI) and bacteraemia on QoL (including frailty and autonomy) in 65+ aged population.

Secondary

MeasureTime frame
Describe the etiology of ARI and bacteremia in aged population Stratify the impact of ARI and bacteremia on QoL and frailty by different infectious diseases Stratify by different outcomes measures (autonomy, frailty, disability) Stratify by health care setting and country Morbidity and mortality evaluation following hospitalization.

Countries

France, Germany, Italy, Spain

Contacts

Public ContactMaria Cristina Polidori Nelles

Uniklinik Köln - Zentrum für Innere Medizin

maria.polidori-nelles@uk-koeln.de004922147832753

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026